NERV stock is currently trading at $1.67 as of February 28, 2025. The bull's view on NERV is cautious due to its weak financial performance, including a Q2 2024 EPS miss (-$1.09 vs. -$0.97 expected) and no reported revenue, which raises concerns about its growth potential. However, analysts have a price target of $11, suggesting significant upside if the company can improve its fundamentals and meet expectations.